MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 36 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,310 | -93.7% | 12,347 | -84.1% | 0.00% | – |
| Q2 2023 | $116,342 | +78.2% | 77,561 | +104.3% | 0.00% | – |
| Q1 2023 | $65,303 | -69.4% | 37,967 | -79.6% | 0.00% | – |
| Q4 2022 | $213,550 | -71.3% | 185,695 | -34.9% | 0.00% | – |
| Q3 2022 | $745,000 | -57.9% | 285,461 | -65.0% | 0.00% | – |
| Q2 2022 | $1,771,000 | -58.2% | 816,318 | -10.2% | 0.00% | -100.0% |
| Q1 2022 | $4,234,000 | +12.2% | 908,576 | +45.8% | 0.00% | – |
| Q4 2021 | $3,775,000 | -21.5% | 623,034 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $4,811,000 | +6.9% | 668,151 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $4,500,000 | – | 714,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |